威高股份(01066.HK)2024年擁有人應佔純利20.67億元 同比增長3.2%
格隆匯3月26日丨威高股份(01066.HK)公告,截至2024年12月31日止年度,錄得收入約人民幣130.87億元,較上一年度下降1.1%;公司擁有人應佔純利約人民幣20.67億元,較上一年度增長3.2%。董事建議派付末期股息每股人民幣0.1235元(2023年:人民幣0.0943元),該項建議須經公司股東在即將舉行的股東大會上批準後,方可作實。
2024年全球醫療器械市場保持增長,公司各業務板塊產品銷量繼續保持增長趨勢,核心產品市場佔有率進一步鞏固,品牌影響力持續加強。
國內公立醫院集中帶量採購政策對公司部分產品價格和利潤的影響已逐步趨於穩定。公司將這一政策視爲國內醫療市場的常態化措施,並積極通過參與投標、優化市場策略等方式,努力擴大市場份額,提升競爭力。
公司堅持產品佈局與業務佈局雙引擎驅動的策略,穩步推動業績增長。在新產品方面,公司持續推動創新研發,不斷完善和豐富產品組合,並制定了清晰的中長期產品規劃,爲未來發展奠定堅實基礎。在業務佈局方面,公司針對國內不同區域及海外市場的特點,制定了差異化的拓展策略,並配置了相應的資源,以全面提升市場滲透率和競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.